All In Biotech

Free tool

FAERS Monitor: Anectine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 008453 or its brand name (Anectine, Succinylcholine Chloride). Reports on generic versions are filed under their own applications.

Reports

2,145

Serious

1,809

84% of reports

Hospitalization

734

Death reported

252

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective249
  • hypotension184
  • cardiac arrest164
  • anaphylactic shock147
  • drug interaction127
  • renal failure118
  • pain114
  • anaphylactic reaction112
  • renal impairment106
  • anxiety102
  • injury101
  • hyperthermia malignant98
  • unevaluable event93
  • maternal exposure during pregnancy91
  • emotional distress88

Reports by year received

View as table
YearReports
200493
200532
200644
200751
200853
200958
201074
2011208
201296
201332
201425
201557
201674
201794
201892
2019158
2020156
2021133
2022131
2023125
2024106
2025162
202691

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,014 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperthermia malignantSignal98691.5565.962,481
anaphylactic shockSignal14756.248.17,885
anaphylactic reactionSignal11219.916.61,994
cardiac arrestSignal16419.516.82,868
injurySignal10114.111.71,219
renal impairmentSignal10612.410.31,101
unevaluable eventSignal9312.19.9935
maternal exposure during pregnancySignal9110.08.2732
hypotensionSignal1849.07.81,312
renal failureSignal1188.77.3803
drug interactionSignal1277.96.6758
emotional distressSignal887.15.8460
anxietySignal1023.52.9183
drug ineffective2491.91.6103
pain1141.81.543

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.